Your browser is no longer supported. Please, upgrade your browser.
Stryker Corporation
IndexS&P 500 P/E48.95 EPS (ttm)4.97 Insider Own0.10% Shs Outstand377.10M Perf Week-7.66%
Market Cap90.43B Forward P/E23.88 EPS next Y10.20 Insider Trans-29.06% Shs Float349.39M Perf Month-9.29%
Income1.90B PEG3.67 EPS next Q3.42 Inst Own76.10% Short Float0.81% Perf Quarter-11.16%
Sales16.67B P/S5.43 EPS this Y-23.30% Inst Trans1.26% Short Ratio2.56 Perf Half Y-4.80%
Book/sh37.60 P/B6.48 EPS next Y11.80% ROA5.60% Target Price286.32 Perf Year4.59%
Cash/sh7.11 P/C34.27 EPS next 5Y13.35% ROE13.90% 52W Range220.90 - 281.16 Perf YTD-0.63%
Dividend2.52 P/FCF43.33 EPS past 5Y2.20% ROI6.90% 52W High-13.39% Beta0.97
Dividend %1.03% Quick Ratio1.40 Sales past 5Y7.60% Gross Margin62.60% 52W Low10.23% ATR5.49
Employees43000 Current Ratio2.10 Sales Q/Q11.30% Oper. Margin15.10% RSI (14)26.96 Volatility2.00% 2.04%
OptionableYes Debt/Eq0.89 EPS Q/Q-29.90% Profit Margin11.40% Rel Volume1.96 Prev Close243.48
ShortableYes LT Debt/Eq0.89 EarningsOct 28 AMC Payout50.00% Avg Volume1.10M Price243.50
Recom2.20 SMA20-8.08% SMA50-8.71% SMA200-5.96% Volume2,137,450 Change0.01%
Sep-14-21Resumed Raymond James Mkt Perform
Jul-28-21Upgrade Northland Capital Market Perform → Outperform $248 → $310
Jun-01-21Upgrade Evercore ISI In-line → Outperform $260 → $285
May-25-21Initiated Barclays Underweight $280
Oct-06-20Initiated Northland Capital Market Perform $225
Sep-11-20Initiated Wolfe Research Peer Perform $230
Apr-13-20Downgrade Barclays Equal Weight → Underweight $155
Apr-01-20Downgrade Goldman Buy → Sell $248 → $150
Mar-05-20Initiated Citigroup Buy $235
Feb-13-20Initiated Goldman Buy $248
Jan-08-20Initiated SunTrust Hold $217
Jan-07-20Downgrade Piper Sandler Overweight → Neutral $210
Jan-07-20Downgrade Piper Jaffray Overweight → Neutral $210
Dec-30-19Reiterated BTIG Research Buy $228 → $236
Nov-05-19Downgrade Barclays Overweight → Equal Weight $226 → $207
Oct-30-19Reiterated BofA/Merrill Buy $220 → $245
Jul-02-19Downgrade Evercore ISI Outperform → In-line
Jan-30-19Reiterated Canaccord Genuity Buy $185 → $190
Jan-03-19Initiated Deutsche Bank Buy $179
Jan-02-19Upgrade Evercore ISI In-line → Outperform
Nov-27-21 01:00PM  
Nov-23-21 08:00AM  
Nov-22-21 11:40AM  
Nov-17-21 11:34AM  
Nov-15-21 10:47AM  
Nov-08-21 01:38PM  
Nov-02-21 03:33AM  
Oct-29-21 10:33AM  
Oct-28-21 05:25PM  
Oct-22-21 08:24AM  
Oct-21-21 03:03PM  
Oct-20-21 09:49AM  
Oct-14-21 01:04PM  
Oct-13-21 10:00AM  
Oct-11-21 11:00AM  
Oct-04-21 12:10PM  
Sep-24-21 08:20AM  
Sep-23-21 11:30AM  
Sep-17-21 08:22AM  
Sep-13-21 01:26PM  
Sep-09-21 08:27AM  
Sep-02-21 09:51AM  
Sep-01-21 08:15PM  
Aug-30-21 08:30AM  
Aug-18-21 01:23PM  
Aug-17-21 03:07PM  
Aug-05-21 08:49AM  
Aug-04-21 08:00AM  
Jul-30-21 12:17PM  
Jul-29-21 01:20PM  
Jul-28-21 04:32PM  
Jul-27-21 11:31PM  
Jul-26-21 08:42AM  
Jul-21-21 07:55AM  
Jul-20-21 03:02PM  
Jul-14-21 08:38AM  
Jul-13-21 02:21PM  
Jul-05-21 11:40AM  
Jun-28-21 12:58PM  
Jun-25-21 02:35AM  
Jun-24-21 04:48PM  
Jun-23-21 09:42AM  
Jun-21-21 11:09AM  
Jun-10-21 05:57AM  
Jun-07-21 11:40AM  
Jun-05-21 09:19AM  
Jun-04-21 04:22PM  
May-27-21 11:31AM  
May-25-21 06:35AM  
May-21-21 11:40AM  
May-10-21 03:53PM  
May-04-21 04:05PM  
May-03-21 07:56AM  
Apr-29-21 02:19AM  
Apr-28-21 09:16AM  
Apr-27-21 04:05PM  
Apr-26-21 10:00AM  
Apr-23-21 09:04AM  
Apr-22-21 04:31PM  
Apr-20-21 12:10PM  
Apr-13-21 06:10AM  
Apr-09-21 04:07PM  
Mar-29-21 02:30PM  
Mar-26-21 08:38AM  
Mar-24-21 03:00PM  
Mar-16-21 08:54AM  
Feb-25-21 08:00AM  
Feb-17-21 02:00PM  
Feb-13-21 10:00AM  
Feb-09-21 07:30AM  
Feb-02-21 04:05PM  
Jan-28-21 10:45AM  
Jan-27-21 10:31PM  
Stryker Corporation operates as a medical technology company. The company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Orthopaedics segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. The Neurotechnology and Spine segment provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Datar Srikant M.DirectorNov 11Sale263.121,000263,1211,533Nov 15 09:25 AM
Stiles Spencer SGroup PresidentNov 01Option Exercise0.001,644028,251Nov 03 05:36 PM
Datar Srikant M.DirectorSep 09Option Exercise64.012,000128,0202,991Sep 13 03:31 PM
STRYKER RONDA EDirectorAug 06Sale262.26150,00039,339,0906,585,726Aug 10 08:13 PM
Fletcher Robert SVP, Chief Legal OfficerAug 05Sale261.101,120292,4364,533Aug 06 08:56 PM
Scannell Timothy JPresident and COOAug 01Option Exercise0.003,6590221,579Aug 03 06:18 PM
Suri RajeevDirectorMay 05Option Exercise0.0099102,976May 07 01:31 PM
STRYKER RONDA EDirectorMay 05Option Exercise0.0099106,663May 07 01:30 PM
Golston Allan C.DirectorMay 05Option Exercise0.00991010,018May 07 01:24 PM
Doliveux RochDirectorMay 05Option Exercise0.00991023,061May 07 01:22 PM
Datar Srikant M.DirectorMay 05Option Exercise0.009910991May 07 01:18 PM
BRAINERD MARY KDirectorMay 05Option Exercise0.0099103,576May 07 01:17 PM
Lobo KevinChair and CEOMay 04Sale255.79107,79527,573,14263,978May 06 08:36 PM
Lobo KevinChair and CEOMay 03Option Exercise55.66107,7955,999,870171,773May 06 08:36 PM
Menon VijuGroup PresidentMay 01Option Exercise0.003,44307,721May 04 05:19 PM
Fletcher Robert SVP, Chief Legal OfficerApr 30Option Exercise0.004,27207,150May 04 04:52 PM
Berry William E JrVP, Corporate ControllerApr 30Sale261.285,0111,309,2560May 04 04:48 PM
Berry William E JrVP, Corporate ControllerApr 12Option Exercise78.639,100715,5059,601Apr 14 05:11 PM
Fink M KathrynVP, Chief HR OfficerApr 08Sale250.004,0001,000,00010,243Apr 12 11:42 AM
Berry William E JrVP, Corporate ControllerMar 21Option Exercise0.001,11901,205Mar 23 07:50 PM
Boehnlein Glenn SVP, Chief Financial OfficerMar 01Sale246.012,000492,02812,321Mar 03 07:49 PM
STRYKER RONDA EDirectorFeb 08Option Exercise59.704,735282,68081,672Feb 10 04:48 PM
Boehnlein Glenn SVP, Chief Financial OfficerDec 28Sale239.102,000478,20914,321Dec 29 02:19 PM
Lobo KevinChairman and CEODec 07Option Exercise53.6027,9851,499,99698,376Dec 09 01:20 PM
Lobo KevinChairman and CEODec 07Sale236.2810,6972,527,53470,391Dec 09 01:20 PM